205 related articles for article (PubMed ID: 32870508)
1. Gut microbiome diversity in acute severe colitis is distinct from mild to moderate ulcerative colitis.
Kedia S; Ghosh TS; Jain S; Desigamani A; Kumar A; Gupta V; Bopanna S; Yadav DP; Goyal S; Makharia G; Travis SPL; Das B; Ahuja V
J Gastroenterol Hepatol; 2021 Mar; 36(3):731-739. PubMed ID: 32870508
[TBL] [Abstract][Full Text] [Related]
2. Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease.
Kedia S; Jain S; Goyal S; Bopanna S; Yadav DP; Sachdev V; Sahni P; Pal S; Dash NR; Makharia G; Travis SPL; Ahuja V
Dig Dis Sci; 2018 Oct; 63(10):2747-2753. PubMed ID: 29948556
[TBL] [Abstract][Full Text] [Related]
3. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
[TBL] [Abstract][Full Text] [Related]
4. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
[TBL] [Abstract][Full Text] [Related]
5. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.
Maldonado-Arriaga B; Sandoval-Jiménez S; Rodríguez-Silverio J; Lizeth Alcaráz-Estrada S; Cortés-Espinosa T; Pérez-Cabeza de Vaca R; Licona-Cassani C; Gámez-Valdez JS; Shaw J; Mondragón-Terán P; Hernández-Cortez C; Suárez-Cuenca JA; Castro-Escarpulli G
Microbiologyopen; 2021 Mar; 10(2):e1181. PubMed ID: 33970546
[TBL] [Abstract][Full Text] [Related]
6. Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study.
Chen DL; Dai YC; Zheng L; Chen YL; Zhang YL; Tang ZP
Medicine (Baltimore); 2021 Feb; 100(7):e24845. PubMed ID: 33607855
[TBL] [Abstract][Full Text] [Related]
7. Gut microbial signatures in clinically stable ulcerative colitis according to the mucosal state and associated symptoms.
Kim S; Jung Y; Lee SB; Oh HS; Hong SN
J Gastroenterol Hepatol; 2024 Feb; 39(2):319-327. PubMed ID: 38054580
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.
Zhang YL; Cai LT; Qi JY; Lin YZ; Dai YC; Jiao N; Chen YL; Zheng L; Wang BB; Zhu LX; Tang ZP; Zhu RX
World J Gastroenterol; 2019 Jul; 25(25):3242-3255. PubMed ID: 31333315
[TBL] [Abstract][Full Text] [Related]
10. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
11. Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients.
Mar JS; LaMere BJ; Lin DL; Levan S; Nazareth M; Mahadevan U; Lynch SV
mBio; 2016 Aug; 7(4):. PubMed ID: 27531910
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
13. A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach.
Barberio B; Facchin S; Patuzzi I; Ford AC; Massimi D; Valle G; Sattin E; Simionati B; Bertazzo E; Zingone F; Savarino EV
Gut Microbes; 2022; 14(1):2028366. PubMed ID: 35129058
[TBL] [Abstract][Full Text] [Related]
14. Overrepresentation of Enterobacteriaceae and
Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Crohn's disease and ulcerative colitis using the microbiome.
Kang DY; Park JL; Yeo MK; Kang SB; Kim JM; Kim JS; Kim SY
BMC Microbiol; 2023 Nov; 23(1):336. PubMed ID: 37951857
[TBL] [Abstract][Full Text] [Related]
16. Adsorptive granulomonocytapheresis alters the gut bacterial microbiota in patients with active ulcerative colitis.
Chen X; Lou L; Tang H; Tan X; Bi J; Wu H; Li N; Wang Y; Mao J
J Clin Apher; 2021 Jun; 36(3):454-464. PubMed ID: 33598970
[TBL] [Abstract][Full Text] [Related]
17. Gut colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae may increase disease activity in biologic-naive outpatients with ulcerative colitis: an interim analysis.
Skuja V; Derovs A; Pekarska K; Rudzite D; Lavrinovica E; Piekuse L; Kempa I; Straume Z; Eglite J; Lejnieks A; Krumina A; Eliakim R
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):92-100. PubMed ID: 29076938
[TBL] [Abstract][Full Text] [Related]
18. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the gut microbiome of children with severe ulcerative colitis.
Michail S; Durbin M; Turner D; Griffiths AM; Mack DR; Hyams J; Leleiko N; Kenche H; Stolfi A; Wine E
Inflamm Bowel Dis; 2012 Oct; 18(10):1799-808. PubMed ID: 22170749
[TBL] [Abstract][Full Text] [Related]
20. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
He X; Liu J; Long G; Xia XH; Liu M
Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
